Then, aiming to validate whether the PI3K/AKT/mTOR signaling pathway was involved in 4-HD inhibiting the migration and invasion of HCC cells, LY294002 was incubated with HepG2 cells, followed by wound healing and Transwell experiments. The gene discussed is MTOR; the disease is hepatocellular carcinoma.